Comparison of efficacy and safety of escitalopram and vilazodone in major depressive disorder
Background: Major depressive disorder (MDD) is a worldwide prevalent psychiatric ailment associated with significant morbidity and mortality. Escitalopram is an effective selective serotonin reuptake inhibitor (SSRI), and vilazodone is a newer SSRI and partial serotonin receptor agonist approved for...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Eldaghayes Publisher
2018-08-01
|
| Series: | National Journal of Physiology, Pharmacy and Pharmacology |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=296243 |
| Tags: |
No Tags, Be the first to tag this record!
|